| | | | | | | | | | | | | | | | | | | | | |
<?xml version="1.0" standalone="no" encoding="windows-1252"?> |
<!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.15b --> |
<!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com --> |
<!-- Field: Doc-Info; Name: Status; Value: 0x00000000 --> |
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"> |
| <link:roleRef roleURI="http://preaxiahealthcare.com/role/Cover" xlink:href="paxh-20220531.xsd#Cover" xlink:type="simple"/> |
| <link:roleRef roleURI="http://preaxiahealthcare.com/role/ConsolidatedBalanceSheets" xlink:href="paxh-20220531.xsd#ConsolidatedBalanceSheets" xlink:type="simple"/> |
| <link:roleRef roleURI="http://preaxiahealthcare.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="paxh-20220531.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple"/> |
| <link:roleRef roleURI="http://preaxiahealthcare.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:href="paxh-20220531.xsd#ConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:type="simple"/> |
| <link:roleRef roleURI="http://preaxiahealthcare.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit" xlink:href="paxh-20220531.xsd#ConsolidatedStatementsOfChangesInStockholdersDeficit" xlink:type="simple"/> |
| <link:roleRef roleURI="http://preaxiahealthcare.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="paxh-20220531.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple"/> |
| <link:roleRef roleURI="http://preaxiahealthcare.com/role/OrganizationAndDescriptionOfBusiness" xlink:href="paxh-20220531.xsd#OrganizationAndDescriptionOfBusiness" xlink:type="simple"/> |
| <link:roleRef roleURI="http://preaxiahealthcare.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="paxh-20220531.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple"/> |
| <link:roleRef roleURI="http://preaxiahealthcare.com/role/RecentAccountingPronouncements" xlink:href="paxh-20220531.xsd#RecentAccountingPronouncements" xlink:type="simple"/> |
| <link:roleRef roleURI="http://preaxiahealthcare.com/role/RelatedPartyTransactions" xlink:href="paxh-20220531.xsd#RelatedPartyTransactions" xlink:type="simple"/> |
| <link:roleRef roleURI="http://preaxiahealthcare.com/role/IncomeTaxes" xlink:href="paxh-20220531.xsd#IncomeTaxes" xlink:type="simple"/> |
| <link:roleRef roleURI="http://preaxiahealthcare.com/role/StockholdersDeficit" xlink:href="paxh-20220531.xsd#StockholdersDeficit" xlink:type="simple"/> |
| <link:roleRef roleURI="http://preaxiahealthcare.com/role/ContingenciesAndCommitments" xlink:href="paxh-20220531.xsd#ContingenciesAndCommitments" xlink:type="simple"/> |
| <link:roleRef roleURI="http://preaxiahealthcare.com/role/SubsequentEvents" xlink:href="paxh-20220531.xsd#SubsequentEvents" xlink:type="simple"/> |
| <link:roleRef roleURI="http://preaxiahealthcare.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="paxh-20220531.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple"/> |
| <link:roleRef roleURI="http://preaxiahealthcare.com/role/IncomeTaxesTables" xlink:href="paxh-20220531.xsd#IncomeTaxesTables" xlink:type="simple"/> |
| <link:roleRef roleURI="http://preaxiahealthcare.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" xlink:href="paxh-20220531.xsd#OrganizationAndDescriptionOfBusinessDetailsNarrative" xlink:type="simple"/> |
| <link:roleRef roleURI="http://preaxiahealthcare.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="paxh-20220531.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple"/> |
| <link:roleRef roleURI="http://preaxiahealthcare.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="paxh-20220531.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple"/> |
| <link:roleRef roleURI="http://preaxiahealthcare.com/role/IncomeTaxesDetails" xlink:href="paxh-20220531.xsd#IncomeTaxesDetails" xlink:type="simple"/> |
| <link:roleRef roleURI="http://preaxiahealthcare.com/role/IncomeTaxesDetailsNarrative" xlink:href="paxh-20220531.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple"/> |
| <link:roleRef roleURI="http://preaxiahealthcare.com/role/StockholdersDeficitDetailsNarrative" xlink:href="paxh-20220531.xsd#StockholdersDeficitDetailsNarrative" xlink:type="simple"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://preaxiahealthcare.com/role/Cover" xlink:title="00000001 - Document - Cover"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://preaxiahealthcare.com/role/ConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONSOLIDATED BALANCE SHEETS"> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue"/> |
| | <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets"/> |
| | <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent"/> |
| | <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:label="loc_us-gaapAccountsPayableRelatedPartiesCurrent"/> |
| | <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableRelatedPartiesCurrent" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrent"/> |
| | <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDueToRelatedPartiesCurrent" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableCurrent" xlink:label="loc_us-gaapLoansPayableCurrent"/> |
| | <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapLoansPayableCurrent" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesAndLoansPayableCurrent" xlink:label="loc_us-gaapNotesAndLoansPayableCurrent"/> |
| | <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapNotesAndLoansPayableCurrent" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent"/> |
| | <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="loc_us-gaapConvertibleNotesPayableCurrent"/> |
| | <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapConvertibleNotesPayableCurrent" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities"/> |
| | <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue"/> |
| | <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital"/> |
| | <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax"/> |
| | <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit"/> |
| | <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity"/> |
| | <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1"/> |
| | <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1"/> |
| | </link:calculationLink> |
| <link:calculationLink xlink:type="extended" xlink:role="http://preaxiahealthcare.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://preaxiahealthcare.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:title="00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS"> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses"/> |
| | <link:loc xlink:type="locator" xlink:href="paxh-20220531.xsd#paxh_ConsultingFees" xlink:label="loc_paxhConsultingFees"/> |
| | <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_paxhConsultingFees" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees"/> |
| | <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense"/> |
| | <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense"/> |
| | <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues"/> |
| | <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1"/> |
| | <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1"/> |
| | </link:calculationLink> |
| <link:calculationLink xlink:type="extended" xlink:role="http://preaxiahealthcare.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficit" xlink:title="00000005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://preaxiahealthcare.com/role/ConsolidatedStatementsOfCashFlows" xlink:title="00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS"> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss"/> |
| | <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableRelatedParties"/> |
| | <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableRelatedParties" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/> |
| | <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt"/> |
| | <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapRepaymentsOfRelatedPartyDebt"/> |
| | <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfRelatedPartyDebt" xlink:type="arc" weight="-1"/> |
| | <link:loc xlink:type="locator" xlink:href="paxh-20220531.xsd#paxh_ProceedsFromIssuanceOfLiabilityForUnissuedShares" xlink:label="loc_paxhProceedsFromIssuanceOfLiabilityForUnissuedShares"/> |
| | <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_paxhProceedsFromIssuanceOfLiabilityForUnissuedShares" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRepaymentsOfRelatedPartyDebt"/> |
| | <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromRepaymentsOfRelatedPartyDebt" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/> |
| | <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities"/> |
| | <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1"/> |
| | <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1"/> |
| | </link:calculationLink> |
| <link:calculationLink xlink:type="extended" xlink:role="http://preaxiahealthcare.com/role/OrganizationAndDescriptionOfBusiness" xlink:title="00000007 - Disclosure - Organization and Description of Business"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://preaxiahealthcare.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - Summary of Significant Accounting Policies"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://preaxiahealthcare.com/role/RecentAccountingPronouncements" xlink:title="00000009 - Disclosure - Recent Accounting Pronouncements"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://preaxiahealthcare.com/role/RelatedPartyTransactions" xlink:title="00000010 - Disclosure - Related Party Transactions"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://preaxiahealthcare.com/role/IncomeTaxes" xlink:title="00000011 - Disclosure - Income Taxes"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://preaxiahealthcare.com/role/StockholdersDeficit" xlink:title="00000012 - Disclosure - Stockholders’ Deficit"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://preaxiahealthcare.com/role/ContingenciesAndCommitments" xlink:title="00000013 - Disclosure - Contingencies and Commitments"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://preaxiahealthcare.com/role/SubsequentEvents" xlink:title="00000014 - Disclosure - Subsequent Events"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://preaxiahealthcare.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000015 - Disclosure - Summary of Significant Accounting Policies (Policies)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://preaxiahealthcare.com/role/IncomeTaxesTables" xlink:title="00000016 - Disclosure - Income Taxes (Tables)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://preaxiahealthcare.com/role/OrganizationAndDescriptionOfBusinessDetailsNarrative" xlink:title="00000017 - Disclosure - Organization and Description of Business (Details Narrative)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://preaxiahealthcare.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000018 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://preaxiahealthcare.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000019 - Disclosure - Related Party Transactions (Details Narrative)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://preaxiahealthcare.com/role/IncomeTaxesDetails" xlink:title="00000020 - Disclosure - Income Taxes (Details)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://preaxiahealthcare.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000021 - Disclosure - Income Taxes (Details Narrative)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://preaxiahealthcare.com/role/StockholdersDeficitDetailsNarrative" xlink:title="00000022 - Disclosure - Stockholders’ Deficit (Details Narrative)"/> |
| </link:linkbase> |